2026 Glenn Dranoff: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	National Ranking	Publications	Citations
Immunology	90	1059	571	229	38094
Medicine	90	12043	6175	231	38094

Overview

Glenn Dranoff is affiliated with Harvard Medical School in the United States and focuses on research within the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work is predominantly centered on Oncology, Immunology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

The scientist's research primarily explores topics related to cancer immunotherapy, including Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune cells in cancer, Immune Cell Function and Interaction, Protein Degradation and Inhibitors, and Galectins and Cancer Biology.

Dranoff has co-authored publications notably with Viviana Cremasco, Pushpa Jayaraman, Angelo L. Grauel, David A. Ruddy, and Tyler Laszewski, indicating ongoing collaborations in their research community.

Their recent papers include the following:

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts, 2020, Nature Communications
A vaccine targeting resistant tumours by dual T cell plus NK cell attack, 2022, Nature
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy, 2023, Cell chemical biology
Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing, 2022, PLoS Biology
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms, 2021, Scientific Reports

The frequent publication venues for Dranoff's work include Cancer Immunology Research, Cell chemical biology, UNC Libraries, Regular and Young Investigator Award Abstracts, and Nature Communications.

Best Publications

Combining immunotherapy and targeted therapies in cancer treatment

Matthew Vanneman;Glenn Dranoff;Glenn Dranoff

2093
Citations
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Grit S. Herter-Sprie

1601
Citations
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

Esra A. Akbay;Esra A. Akbay;Shohei Koyama;Julian Carretero;Abigail Altabef;Abigail Altabef

1347
Citations
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

F. Stephen Hodi;Martin C. Mihm;Robert J. Soiffer;Frank G. Haluska

1197
Citations
High-throughput oncogene mutation profiling in human cancer

Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

1183
Citations
Coinhibitory Pathways in Immunotherapy for Cancer.

Susanne H Baumeister;Gordon J Freeman;Glenn Dranoff;Glenn Dranoff;Arlene H Sharpe

1065
Citations
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

Kosuke Mima;Reiko Nishihara;Zhi Rong Qian;Yin Cao

1057
Citations
Prospects for combining targeted and conventional cancer therapy with immunotherapy

Philip Gotwals;Scott Cameron;Daniela Cipolletta;Viviana Cremasco

891
Citations
Immune therapy for cancer.

Michael Dougan;Glenn Dranoff

885
Citations
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

R Soiffer;T Lynch;M Mihm;K Jung

866
Citations
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

F. Stephen Hodi;Marcus Butler;Darryl A. Oble;Michael V. Seiden;Michael V. Seiden

825
Citations
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

Norimoto Kobayashi;Piia Karisola;Victor Peña-Cruz;David M. Dorfman

770
Citations
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie

676
Citations
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites

Chris S. Lantz;Jurg Boesiger;Chang Ho Song;Nicolas Mach

674
Citations
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Kosuke Mima;Yasutaka Sukawa;Reiko Nishihara;Zhi Rong Qian

658
Citations
STK11/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T cell activity in the lung tumor microenvironment

Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Amir R. Aref

642
Citations
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Pakawat Chongsathidkiet;Christina Jackson;Shohei Koyama;Franziska Loebel

634
Citations
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka;Pakawat Chongsathidkiet;Kristen Rhodin;Hanna Kemeny

631
Citations
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

Yannick Bulliard;Rose Jolicoeur;Maurice Windman;Sarah M. Rue

620
Citations
Differences in Dendritic Cells Stimulated in Vivo by Tumors Engineered to Secrete Granulocyte-Macrophage Colony-stimulating Factor or Flt3-Ligand

N Mach;S Gillessen;S B Wilson;C Sheehan

611
Citations
Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review†

Katsuhiko Nosho;Yoshifumi Baba;Noriko Tanaka;Kaori Shima

566
Citations

Frequent Co-Authors

F. Stephen Hodi Harvard University

Gordon J. Freeman Harvard University

Jerome Ritz Harvard University

Robert J. Soiffer Harvard University

Martin C. Mihm Brigham and Women's Hospital

Kwok-Kin Wong New York University

Richard C. Mulligan Harvard University

Edwin P. Alyea Harvard University

Scott J. Rodig Harvard University

Donna Neuberg Harvard University

External Links

Personal website of Glenn Dranoff

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. One popular path is becoming a Nurse Practitioner, with programs varying widely in difficulty. If you’re seeking flexible options, consider reviewing which nurse practitioner program is easiest to find the right fit for your schedule and learning style.

Mental health specialties, such as Psychiatric-Mental Health Nurse Practitioner (PMHNP), offer rewarding careers with growing demand. When selecting a program, it's important to consider clinical experience, so looking at the best pmhnp programs with high clinical placement rates can ensure hands-on learning crucial for this field.

Cost is another key factor for many students. If affordability is a priority, exploring the cheapest online pmhnp certificate programs can help you pursue your goals without excessive financial burden.

After completing advanced degrees like a Doctor of Nursing Practice (DNP), salaries vary significantly by location. To maximize your earning potential, it's useful to review the average dnp salary by state before committing to a program or region.

By understanding these pathways and evaluating program options, you can strategically plan a career that complements your interests in Immunology and healthcare.